4 results match your criteria: "Kanungo Institute of Diabetes Specialities[Affiliation]"
Med Sci (Basel)
May 2021
Department of Internal Medicine, Pondicherry Institute of Medical Sciences, Kalathumettupathai, Ganapathichettikulam Village, No 20, Kalapet, Puducherry 6050146, India.
Evidence suggests a major contribution of postprandial glucose (PPG) excursions to the increased risk of micro- and macro-vascular complications in individuals with type 2 diabetes mellitus (T2DM). Administration of bolus insulin remains a very effective therapeutic option for PPG control. The aim of this expert group recommendation document was to provide practical and easy-to-execute guidelines for physicians on the appropriate use of bolus insulin in the management of T2DM.
View Article and Find Full Text PDFDiabet Med
January 2016
Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Aim: Killer immunoglobulin-like receptors (KIRs) and their interaction with HLA class I ligands have been shown to be associated with Type 1 diabetes mellitus. The aim of our study was to investigate the influence of KIR genes and their HLA-C ligands for susceptibility to Type 1 diabetes in patients from Eastern India.
Methods: A total of 135 patients with Type 1 diabetes and 98 healthy subjects from Eastern India were typed for KIR genes and HLA-C ligands using PCR-based genotyping.
Indian J Endocrinol Metab
April 2015
Consultant Endocrinologist, PD Hinduja National Hospital and Hope and Care Centre, Vashi, Mumbai, Maharashtra, India.
Type 1 diabetes mellitus (T1DM) has a wide presence in children and has a high mortality rates. The disease, if left unmanaged, poses various challenges to the patient and healthcare providers, including development of diabetic complications and thus decreasing the life expectancy of the affected child. The challenges of T1DM include awareness of the disease that is very poor among the general public and also in parents of T1DM children along with the health care professionals.
View Article and Find Full Text PDFIndian J Endocrinol Metab
April 2015
Founder and Chairman, Consultant Diabetologist, Kanungo Institute of Diabetes Specialities, Bhubaneswar, Odisha, India ; Founder of and Chief Consultant of Diabetology, Cuttack Diabetes Research Foundation, Bhubaneswar, Odisha, India.
Not all healthcare professionals (HCPs) are aware of type 1 diabetes mellitus (T1DM) and various myths still exist in the society and among HCPs. The medical challenge in treating T1DM is the confusion between T1DM and T2DM and its management, which is very common and is observed with both general practitioners and parents of children with diabetes. There are multiple medical and social myths associated with diabetes, especially T1DM, prevalent in society.
View Article and Find Full Text PDF